Home | Archives | Products | About | Contact | FAQ |
New User? Sign Up | Sign In
insider trading reports Form 4 Filings Insider Buys Significant Buys Penny Stocks
Insider Buying
Insider Sales
Insider Buy Sell Ratios Stock Options Insider Trading
Stock Screener
Insider Trading
Graph View
Insider Watch

Insider Trading - Aimmune Therapeutics Inc. (AIMT)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
AIMT Insider Trading Transactions for Aimmune Therapeutics  Inc.
Goto page 0, 1, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2018-11-19
Sale
2018-11-21
4:05 pm
Aimmune Therapeutics Inc. AIMT Barrowcliffe Susan E.
General Manager, Europe
40,000 $30.04 $1,201,600 53,400
(Direct)
View
2018-11-19
Purchase
2018-11-19
8:12 pm
Aimmune Therapeutics Inc. AIMT Dallas Jayson Donald Alexander
CEO
3,650 $27.56 $100,587 63,650
(Direct)
View
2018-06-13
Purchase
2018-06-14
4:08 pm
Aimmune Therapeutics Inc. AIMT BJERKHOLT ERIC
CFO
1,600 $30.41 $48,663 19,485
(Direct)
View
2018-06-11
Sale
2018-06-13
4:06 pm
Aimmune Therapeutics Inc. AIMT DILLY STEPHEN GEORGE
CEO
29,457 $30.83 $908,301 344,765
(Indirect
Direct)
View
2018-06-06
Sale
2018-06-08
5:50 pm
Aimmune Therapeutics Inc. AIMT DILLY STEPHEN GEORGE
CEO
105,169 $30.92 $3,251,993 400,103
(Indirect
Direct)
View
2018-06-01
Sale
2018-06-05
7:20 pm
Aimmune Therapeutics Inc. AIMT DILLY STEPHEN GEORGE
Director
165,374 $32.14 $5,315,183 534,745
(Indirect
Direct)
View
2018-05-22
Sale
2018-05-24
5:09 pm
Aimmune Therapeutics Inc. AIMT Sheehy Douglas T.
See Remarks
3,296 $33 $108,768 65,297
(Direct)
View
2018-03-04
Sale
2018-03-06
8:40 pm
Aimmune Therapeutics Inc. AIMT Sheehy Douglas T.
See Remarks
3,523 $36.52 $128,667 75,000
(Direct)
View
2018-03-01
Sale
2018-03-05
4:05 pm
Aimmune Therapeutics Inc. AIMT Rozenman Mary M.
See Remarks
1,807 $33.1 $59,812 105,436
(Direct)
View
2018-02-22
Purchase
2018-02-26
4:25 pm
Aimmune Therapeutics Inc. AIMT Tammenoms Bakker Juliet
10% Owner
9,375 $32 $300,000 6,013,134
(Indirect
Direct)
View
2018-02-22
Purchase
2018-02-26
4:22 pm
Aimmune Therapeutics Inc. AIMT ENRIGHT PATRICK G
Director, 10% Owner
15,593 $32 $498,976 6,013,134
(Indirect
Direct)
View
2018-02-26
Purchase
2018-02-26
4:05 pm
Aimmune Therapeutics Inc. AIMT Iwicki Mark T
Director
9,375 $32 $300,000 29,375
(Direct)
View
2018-02-26
Purchase
2018-02-26
4:05 pm
Aimmune Therapeutics Inc. AIMT FALBERG KATHRYN E
Director
30,000 $32 $960,000 124,894
(Direct)
View
2018-02-26
Purchase
2018-02-26
4:05 pm
Aimmune Therapeutics Inc. AIMT BJERKHOLT ERIC
CFO
3,125 $32 $100,000 8,125
(Direct)
View
2018-02-05
Sale
2018-02-07
4:06 pm
Aimmune Therapeutics Inc. AIMT Sheehy Douglas T.
See Remarks
1,648 $35.87 $59,114 68,593
(Direct)
View
2018-02-01
Sale
2018-02-05
4:05 pm
Aimmune Therapeutics Inc. AIMT Rozenman Mary M.
See Remarks
6,592 $35.36 $233,088 107,243
(Direct)
View
2018-01-24
Sale
2018-01-26
5:32 pm
Aimmune Therapeutics Inc. AIMT Sheehy Douglas T.
See Remarks
1,875 $38.15 $71,531 69,375
(Direct)
View
2018-01-12
Sale
2018-01-16
6:05 pm
Aimmune Therapeutics Inc. AIMT ADELMAN DANIEL C MD
Chief Medical Officer
36,717 $40 $1,468,680 199,933
(Direct)
View
2018-01-04
Sale
2018-01-08
4:07 pm
Aimmune Therapeutics Inc. AIMT Sheehy Douglas T.
See Remarks
1,648 $37.33 $61,520 70,241
(Direct)
View
2018-01-02
Sale
2018-01-04
4:05 pm
Aimmune Therapeutics Inc. AIMT Rozenman Mary M.
See Remarks
6,591 $37.11 $244,590 113,835
(Direct)
View
2018-01-02
Sale
2018-01-04
4:05 pm
Aimmune Therapeutics Inc. AIMT Barrowcliffe Susan E.
General Manager, Europe
75,000 $37.14 $2,785,190 93,400
(Direct)
View
2017-12-27
Sale
2017-12-29
5:26 pm
Aimmune Therapeutics Inc. AIMT ADELMAN DANIEL C MD
Chief Medical Officer
3,283 $40 $131,320 226,717
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-02-22
Option Award
2019-02-26
4:06 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT Sheehy Douglas T.
See Remarks
12,500 $0 75,000
(Direct)
View
2019-02-22
Option Award
2019-02-26
4:06 pm
N/A
2029-02-22
Aimmune Therapeutics Inc. AIMT Sheehy Douglas T.
See Remarks
75,000 $23.72 75,000
(Direct)
View
2019-02-22
Option Award
2019-02-26
4:06 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT ADELMAN DANIEL C MD
Chief Medical Officer
11,875 $0 71,250
(Direct)
View
2019-02-22
Option Award
2019-02-26
4:06 pm
N/A
2029-02-22
Aimmune Therapeutics Inc. AIMT ADELMAN DANIEL C MD
Chief Medical Officer
71,250 $23.72 71,250
(Direct)
View
2019-02-22
Option Award
2019-02-26
4:06 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT BJERKHOLT ERIC
CFO
13,125 $0 78,750
(Direct)
View
2019-02-22
Option Award
2019-02-26
4:06 pm
N/A
2029-02-22
Aimmune Therapeutics Inc. AIMT BJERKHOLT ERIC
CFO
78,750 $23.72 78,750
(Direct)
View
2019-02-22
Option Award
2019-02-26
4:06 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT Rozenman Mary M.
See Remarks
7,500 $0 45,000
(Direct)
View
2019-02-22
Option Award
2019-02-26
4:06 pm
N/A
2029-02-22
Aimmune Therapeutics Inc. AIMT Rozenman Mary M.
See Remarks
45,000 $23.72 45,000
(Direct)
View
2019-02-22
Option Award
2019-02-26
4:05 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT Dallas Jayson Donald Alexander
CEO
35,000 $0 210,000
(Direct)
View
2019-02-22
Option Award
2019-02-26
4:05 pm
N/A
2029-02-22
Aimmune Therapeutics Inc. AIMT Dallas Jayson Donald Alexander
CEO
210,000 $23.72 210,000
(Direct)
View
2019-01-22
Option Award
2019-01-24
4:06 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT Oxtoby Andrew
Chief Commercial Officer
12,000 $0 150,000
(Direct)
View
2019-01-22
Option Award
2019-01-24
4:06 pm
N/A
2029-01-22
Aimmune Therapeutics Inc. AIMT Oxtoby Andrew
Chief Commercial Officer
150,000 $21.94 150,000
(Direct)
View
2018-11-19
Exercise
2018-11-21
4:05 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT Barrowcliffe Susan E.
General Manager, Europe
40,000 $3.022 53,400
(Direct)
View
2018-11-19
Exercise
2018-11-21
4:05 pm
N/A
2025-05-13
Aimmune Therapeutics Inc. AIMT Barrowcliffe Susan E.
General Manager, Europe
40,000 $3.022 53,400
(Direct)
View
2018-06-19
Option Award
2018-06-19
7:06 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT Dallas Jayson Donald Alexander
CEO
60,000 $0 350,000
(Direct)
View
2018-06-19
Option Award
2018-06-19
7:06 pm
N/A
2028-06-19
Aimmune Therapeutics Inc. AIMT Dallas Jayson Donald Alexander
CEO
350,000 $30.68 350,000
(Direct)
View
2018-06-11
Exercise
2018-06-13
4:06 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT DILLY STEPHEN GEORGE
CEO
29,457 $3.022 344,765
(Direct)
View
2018-06-11
Exercise
2018-06-13
4:06 pm
N/A
2025-05-18
Aimmune Therapeutics Inc. AIMT DILLY STEPHEN GEORGE
CEO
29,457 $3.022 344,765
(Direct)
View
2018-06-06
Exercise
2018-06-08
5:50 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT DILLY STEPHEN GEORGE
CEO
30,465 $3.022 400,103
(Direct)
View
2018-06-06
Exercise
2018-06-08
5:50 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT DILLY STEPHEN GEORGE
CEO
32,598 $3.022 400,103
(Direct)
View
2018-06-06
Exercise
2018-06-08
5:50 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT DILLY STEPHEN GEORGE
CEO
42,106 $3.022 400,103
(Direct)
View
2018-06-06
Exercise
2018-06-08
5:50 pm
N/A
2025-05-18
Aimmune Therapeutics Inc. AIMT DILLY STEPHEN GEORGE
CEO
30,465 $3.022 400,103
(Direct)
View
2018-06-06
Exercise
2018-06-08
5:50 pm
N/A
2025-05-18
Aimmune Therapeutics Inc. AIMT DILLY STEPHEN GEORGE
CEO
32,598 $3.022 400,103
(Direct)
View
2018-06-06
Exercise
2018-06-08
5:50 pm
N/A
2025-05-18
Aimmune Therapeutics Inc. AIMT DILLY STEPHEN GEORGE
CEO
42,106 $3.022 400,103
(Direct)
View
2018-06-01
Gift
2018-06-05
7:20 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT DILLY STEPHEN GEORGE
Director
2,438 $0 534,745
(Indirect)
View
2018-06-01
Gift
2018-06-05
7:20 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT DILLY STEPHEN GEORGE
Director
2,438 $0 534,745
(Indirect)
View
2018-06-01
Gift
2018-06-05
7:20 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT DILLY STEPHEN GEORGE
Director
2,438 $0 534,745
(Indirect)
View
2018-06-01
Gift
2018-06-05
7:20 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT DILLY STEPHEN GEORGE
Director
2,438 $0 534,745
(Indirect)
View
2018-06-01
Exercise
2018-06-05
7:20 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT DILLY STEPHEN GEORGE
Director
61,197 $3.022 534,745
(Direct)
View
2018-06-01
Exercise
2018-06-05
7:20 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT DILLY STEPHEN GEORGE
Director
65,352 $3.022 534,745
(Direct)
View
2018-06-01
Exercise
2018-06-05
7:20 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT DILLY STEPHEN GEORGE
Director
38,825 $3.022 534,745
(Direct)
View
2018-06-01
Exercise
2018-06-05
7:20 pm
N/A
2025-05-18
Aimmune Therapeutics Inc. AIMT DILLY STEPHEN GEORGE
Director
61,197 $3.022 534,745
(Direct)
View
2018-06-01
Exercise
2018-06-05
7:20 pm
N/A
2025-05-18
Aimmune Therapeutics Inc. AIMT DILLY STEPHEN GEORGE
Director
65,352 $3.022 534,745
(Direct)
View
2018-06-01
Exercise
2018-06-05
7:20 pm
N/A
2025-05-18
Aimmune Therapeutics Inc. AIMT DILLY STEPHEN GEORGE
Director
38,825 $3.022 534,745
(Direct)
View
2018-05-23
Option Award
2018-05-24
5:09 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT ENRIGHT PATRICK G
Director, 10% Owner
3,750 $0 6,013,134
(Direct)
View
2018-05-23
Option Award
2018-05-24
5:09 pm
N/A
2028-05-23
Aimmune Therapeutics Inc. AIMT ENRIGHT PATRICK G
Director, 10% Owner
7,500 $32.79 6,013,134
(Direct)
View
2018-05-22
Exercise
2018-05-24
5:09 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT Sheehy Douglas T.
See Remarks
1,648 $12.95 65,297
(Direct)
View
2018-05-22
Exercise
2018-05-24
5:09 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT Sheehy Douglas T.
See Remarks
1,648 $12.95 65,297
(Direct)
View
2018-05-22
Exercise
2018-05-24
5:09 pm
N/A
2026-04-29
Aimmune Therapeutics Inc. AIMT Sheehy Douglas T.
See Remarks
1,648 $12.95 65,297
(Direct)
View
2018-05-22
Exercise
2018-05-24
5:09 pm
N/A
2026-04-29
Aimmune Therapeutics Inc. AIMT Sheehy Douglas T.
See Remarks
1,648 $12.95 65,297
(Direct)
View
2018-05-23
Option Award
2018-05-24
5:09 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT Seltzer Stacey Denenberg
Director
3,750 $0 7,500
(Direct)
View
2018-05-23
Option Award
2018-05-24
5:09 pm
N/A
2028-05-23
Aimmune Therapeutics Inc. AIMT Seltzer Stacey Denenberg
Director
7,500 $32.79 7,500
(Direct)
View
2018-05-23
Option Award
2018-05-24
5:08 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT Behar Gregory
Director
3,750 $0 7,500
(Direct)
View
2018-05-23
Option Award
2018-05-24
5:08 pm
N/A
2028-05-23
Aimmune Therapeutics Inc. AIMT Behar Gregory
Director
7,500 $32.79 7,500
(Direct)
View
2018-05-23
Option Award
2018-05-24
5:06 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT Iwicki Mark T
Director
3,750 $0 33,125
(Direct)
View
2018-05-23
Option Award
2018-05-24
5:06 pm
N/A
2028-05-23
Aimmune Therapeutics Inc. AIMT Iwicki Mark T
Director
7,500 $32.79 33,125
(Direct)
View
2018-05-23
Option Award
2018-05-24
5:06 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT FALBERG KATHRYN E
Director
3,750 $0 128,644
(Direct)
View
2018-05-23
Option Award
2018-05-24
5:06 pm
N/A
2028-05-23
Aimmune Therapeutics Inc. AIMT FALBERG KATHRYN E
Director
7,500 $32.79 128,644
(Direct)
View
2018-05-23
Option Award
2018-05-24
5:05 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT MCDADE MARK
Director
3,750 $0 20,410
(Direct)
View
2018-05-23
Option Award
2018-05-24
5:05 pm
N/A
2028-05-23
Aimmune Therapeutics Inc. AIMT MCDADE MARK
Director
7,500 $32.79 20,410
(Direct)
View
2018-03-04
Option Award
2018-03-06
8:42 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT Barrowcliffe Susan E.
General Manager, Europe
9,375 $0 56,250
(Direct)
View
2018-03-04
Option Award
2018-03-06
8:42 pm
N/A
2028-03-04
Aimmune Therapeutics Inc. AIMT Barrowcliffe Susan E.
General Manager, Europe
56,250 $34.07 56,250
(Direct)
View
2018-03-04
Option Award
2018-03-06
8:42 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT Knapp Jeffrey H
COO
9,375 $0 56,250
(Direct)
View
2018-03-04
Option Award
2018-03-06
8:42 pm
N/A
2028-03-04
Aimmune Therapeutics Inc. AIMT Knapp Jeffrey H
COO
56,250 $34.07 56,250
(Direct)
View
2018-03-04
Option Award
2018-03-06
8:41 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT Rozenman Mary M.
See Remarks
6,875 $0 41,250
(Direct)
View
2018-03-04
Option Award
2018-03-06
8:41 pm
N/A
2028-03-04
Aimmune Therapeutics Inc. AIMT Rozenman Mary M.
See Remarks
41,250 $34.07 41,250
(Direct)
View
2018-03-04
Option Award
2018-03-06
8:40 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT Sheehy Douglas T.
See Remarks
32,500 $0 75,000
(Direct)
View
2018-03-04
Exercise
2018-03-06
8:40 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT Sheehy Douglas T.
See Remarks
1,875 $19.63 75,000
(Direct)
View
2018-03-04
Exercise
2018-03-06
8:40 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT Sheehy Douglas T.
See Remarks
1,648 $12.95 75,000
(Direct)
View
2018-03-04
Option Award
2018-03-06
8:40 pm
N/A
2028-03-04
Aimmune Therapeutics Inc. AIMT Sheehy Douglas T.
See Remarks
75,000 $34.07 75,000
(Direct)
View
2018-03-04
Exercise
2018-03-06
8:40 pm
N/A
2027-02-24
Aimmune Therapeutics Inc. AIMT Sheehy Douglas T.
See Remarks
1,875 $19.63 75,000
(Direct)
View
2018-03-04
Exercise
2018-03-06
8:40 pm
N/A
2026-04-29
Aimmune Therapeutics Inc. AIMT Sheehy Douglas T.
See Remarks
1,648 $12.95 75,000
(Direct)
View
2018-03-04
Option Award
2018-03-06
8:40 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT ADELMAN DANIEL C MD
Chief Medical Officer
9,375 $0 56,250
(Direct)
View
2018-03-04
Option Award
2018-03-06
8:40 pm
N/A
2028-03-04
Aimmune Therapeutics Inc. AIMT ADELMAN DANIEL C MD
Chief Medical Officer
56,250 $34.07 56,250
(Direct)
View
2018-03-04
Option Award
2018-03-06
8:39 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT BJERKHOLT ERIC
CFO
9,375 $0 56,250
(Direct)
View
2018-03-04
Option Award
2018-03-06
8:39 pm
N/A
2028-03-04
Aimmune Therapeutics Inc. AIMT BJERKHOLT ERIC
CFO
56,250 $34.07 56,250
(Direct)
View
2018-03-01
Exercise
2018-03-05
4:05 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT Rozenman Mary M.
See Remarks
1,807 $3.022 105,436
(Direct)
View
2018-03-01
Exercise
2018-03-05
4:05 pm
N/A
2025-04-17
Aimmune Therapeutics Inc. AIMT Rozenman Mary M.
See Remarks
1,807 $3.022 105,436
(Direct)
View
2018-02-05
Exercise
2018-02-07
4:06 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT Sheehy Douglas T.
See Remarks
1,648 $12.95 68,593
(Direct)
View
2018-02-05
Exercise
2018-02-07
4:06 pm
N/A
2026-04-29
Aimmune Therapeutics Inc. AIMT Sheehy Douglas T.
See Remarks
1,648 $12.95 68,593
(Direct)
View
2018-02-01
Exercise
2018-02-05
4:05 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT Rozenman Mary M.
See Remarks
6,592 $3.022 107,243
(Direct)
View
2018-02-01
Exercise
2018-02-05
4:05 pm
N/A
2025-04-17
Aimmune Therapeutics Inc. AIMT Rozenman Mary M.
See Remarks
6,592 $3.022 107,243
(Direct)
View
2018-01-24
Exercise
2018-01-26
5:32 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT Sheehy Douglas T.
See Remarks
1,875 $19.63 69,375
(Direct)
View
2018-01-24
Exercise
2018-01-26
5:32 pm
N/A
2027-02-24
Aimmune Therapeutics Inc. AIMT Sheehy Douglas T.
See Remarks
1,875 $19.63 69,375
(Direct)
View
2018-01-12
Exercise
2018-01-16
6:05 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT ADELMAN DANIEL C MD
Chief Medical Officer
26,784 $11.45 199,933
(Direct)
View
2018-01-12
Exercise
2018-01-16
6:05 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT ADELMAN DANIEL C MD
Chief Medical Officer
9,933 $11.45 199,933
(Direct)
View
2018-01-12
Exercise
2018-01-16
6:05 pm
N/A
2026-06-24
Aimmune Therapeutics Inc. AIMT ADELMAN DANIEL C MD
Chief Medical Officer
26,784 $11.45 199,933
(Direct)
View
2018-01-12
Exercise
2018-01-16
6:05 pm
N/A
2026-06-24
Aimmune Therapeutics Inc. AIMT ADELMAN DANIEL C MD
Chief Medical Officer
9,933 $11.45 199,933
(Direct)
View
2018-01-04
Exercise
2018-01-08
4:07 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT Sheehy Douglas T.
See Remarks
1,648 $12.95 70,241
(Direct)
View
2018-01-04
Exercise
2018-01-08
4:07 pm
N/A
2026-04-29
Aimmune Therapeutics Inc. AIMT Sheehy Douglas T.
See Remarks
1,648 $12.95 70,241
(Direct)
View
2018-01-02
Exercise
2018-01-04
4:05 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT Rozenman Mary M.
See Remarks
6,591 $3.022 113,835
(Direct)
View
2018-01-02
Exercise
2018-01-04
4:05 pm
N/A
2025-04-17
Aimmune Therapeutics Inc. AIMT Rozenman Mary M.
See Remarks
6,591 $3.022 113,835
(Direct)
View
2018-01-02
Exercise
2018-01-04
4:05 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT Barrowcliffe Susan E.
General Manager, Europe
75,000 $3.022 93,400
(Direct)
View
2018-01-02
Exercise
2018-01-04
4:05 pm
N/A
2025-05-13
Aimmune Therapeutics Inc. AIMT Barrowcliffe Susan E.
General Manager, Europe
75,000 $3.022 93,400
(Direct)
View
2017-12-27
Exercise
2017-12-29
5:26 pm
N/A
N/A
Aimmune Therapeutics Inc. AIMT ADELMAN DANIEL C MD
Chief Medical Officer
3,283 $11.45 226,717
(Direct)
View
2017-12-27
Exercise
2017-12-29
5:26 pm
N/A
2026-06-24
Aimmune Therapeutics Inc. AIMT ADELMAN DANIEL C MD
Chief Medical Officer
3,283 $11.45 226,717
(Direct)
View
Goto page 0, 1, Next